Navigating a lung cancer diagnosis can feel overwhelming not only to the patient but to their caregiver as well. It’s normal to feel lost or confused and not know where to start or what resources to ask for. Because a cancer diagnosis is a family diagnosis, LUNGevity wants caregivers to know they don’t have to go through it alone. There are resources available to help caregivers take care of their loved ones as well as themselves. Here are 5 important caregiver resources to help with your loved one’s lung cancer diagnosis. 1) Request a Navigator A Navigator can be a Social Worker, Nurse, or

In August, we were joined by Jacob Sands, MD, Associate Chief of the Lowe Center for Thoracic Oncology and Assistant Professor of Medicine at Harvard Medical School. Dr. Sands discussed The Importance of HOPE: Highlighting Recent Advancements in SCLC. Moderated by Misty Shields, MD, PhD, Indiana University School of Medicine, and LUNGevity’s Upal Basu Roy, PhD, MPH, Executive Director of Research, this monthly virtual series highlights the latest discoveries and breakthroughs for SCLC.

Living with lung cancer can take more than just a physical toll—it comes with a myriad of feelings, like anxiety, fear, and grief. In this episode, non-small cell lung cancer (NSCLC) survivor and advocate Nora Taylor shares her journey through diagnosis, clinical trials, and targeted therapy, along with the rollercoaster of emotions that go with it. Licensed clinical social worker Ashley Griffin joins Nora as well as hosts Ann Steagall and Misty Shields, MD, to explain why anxiety and depression are such a common and often unspoken part of the cancer experience. She offers practical, everyday

LUNGevity offers a variety of virtual support groups called ‘meetups’ where survivors and caregivers impacted by lung cancer connect with others who understand the patient experience. Once a month, we invite an expert to share information on a topic related to life with lung cancer, engage with attendees, and answer questions in real time. Visit the LUNGevity Calendar to see upcoming events like this one. In June, we welcomed Duc Huynh, PharmD, BCOP, MD Anderson Cancer Center, to talk about bone-modifying agents. Topics covered in this 20-minute video include: How do bones naturally change

How do clinical trials work? What actually happens when you enroll in one? And how do you find a trial that's right for you? In this episode, small cell lung cancer survivor Wendy Brooks and thoracic oncologist Arthi Sridhar, MD, UT Southwestern Medical Center, join hosts Ann Steagall and Dr. Misty Shields to break down the intricacies of clinical trials—phases, safeguards in place, and what it's like to be a part of one. Listen as Wendy shares her own experience moving through multiple trials after her cancer progressed on standard treatment. Dr. Sridhar walks through what a clinical trial

In June, we were joined by Charles Rudin, MD, PhD, Memorial Sloan Kettering Cancer Center. Dr. Rudin discussed how participation in clinical trials has brought hope and meaningful change for people with SCLC. Moderated by Misty Shields, MD, PhD, Indiana University School of Medicine, and LUNGevity’s Ann Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs for SCLC.

What are biomarkers, why do they matter, and what should every person living with lung cancer know about getting tested? Dr. Ross Camidge, a world-renowned thoracic oncologist and lung cancer researcher at the University of Colorado, joins Ann Steagall and Dr. Misty Shields to explain the ins and outs of biomarkers. Dr. Camidge helped pioneer biomarker testing as a standard of care, but he also brings the patient perspective as well - he was diagnosed with EGFR-mutant non-small cell lung cancer several years ago. They discuss what biomarkers are, how biomarker testing works, why you might need

LUNGevity offers a variety of virtual support groups called ‘meetups’ where survivors and caregivers impacted by lung cancer connect with others who understand the patient experience. Once a month, we invite an expert to share information on a topic related to life with lung cancer, engage with attendees, and answer questions in real time. In May, we welcomed Aileen Anglin, ACNP-BC, AOCNP, from MD Anderson Cancer Center, to talk about peripheral neuropathy. Peripheral neuropathy refers to the many conditions that involve damage to the nerves outside of the brain and spinal cord. This can lead

How do you make the most of your visits with your healthcare team? In this episode, lung cancer survivor Bill Morris shares his experience with lung cancer and how he approaches his healthcare visits now. Oncology nurse practitioner Rasheda Persinger shares her insights after 20 years of working with patients. Hosts Ann and Dr. Shields discuss with Bill and Rasheda what they wish every patient knew, from writing down questions before an appointment to asking about biomarker testing to why recording your visit can make all the difference. <a href="https:/

In May, we were joined by Simon Heeke, PhD, MD Anderson Cancer Center. Dr. Heeke discussed biomarker identification and their potential roles in patients impacted by SCLC. Moderated by Misty Shields, MD, PhD, Indiana University School of Medicine, and LUNGevity’s Ann Fish-Steagall, SVP of Patient Services and Health Care Delivery, this monthly virtual series highlights the latest discoveries and breakthroughs for SCLC.